For anyone who feels overwhelmed by injections or cant afford real medications, the idea of a patch can feel less like advertising and more like a lifeline
The next phase of research is already underway: brain-penetrant GLP-1s, intranasal delivery, head-to-head neurocognitive trials, and combination approaches that pair metabolic repair with targeted neurobiology
New oral formulations (Wegovy pill, upcoming oral tirzepatide) are cheaper to manufacture than injectables
All answers are self-reported and may underestimate prevalence of clinical conditions
Conclusions and Future Directions In recent years, multiple studies on CVDs have demonstrated the effectiveness of GLP-1RAs in preventing cardiovascular events, including acute myocardial infarction and stroke, and reducing related mortality, including all-cause mortality
Older weight loss medications like phentermine and orlistat achieve modest results (5 to 10% weight loss typically) with significant side effect profiles
